erratum: Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Nature

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1038/47286
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Insights into the Molecular Determinants Involved in Urocontrin and Urocontrin A Action.

  2020cites this paper
• Urotensin-II gene rs228648 polymorphism associated with the risk of diabetes mellitus

  2018cites this paper
• Key molecules and factors – Excessive arterial vasodilation / hypocontractility

  2017cites this paper
• Urotensin II exerts antiapoptotic effect on NRK-52E cells through prostacyclin-mediated peroxisome proliferator-activated receptor alpha and Akt activation.

  2013cites this paper
• Increased expression of urotensin II and GPR14 in patients with cirrhosis and portal hypertension.

  2010cites this paper
• Nonpeptide urotensin-II receptor antagonists: a new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunits.

  2009cites this paper
• Urotensin II: lessons from comparative studies for general endocrinology.

  2008cites this paper
• High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man.

  2002cites this paper